CD79A and COVID-19: A significant correlation between serum and secretory anti-SARS-CoV-2 spike protein IgA (r=0.542; p<0.001) and RBD IgA (r=0.389; p<0.001) has also been reported in COVID-19 patients by Isho and colleagues [23].